药品注册申请号:090132
申请类型:ANDA (仿制药申请)
申请人:SUN PHARM INDUSTRIES
申请人全名:SUN PHARMACEUTICAL INDUSTRIES INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 CARVEDILOL PHOSPHATE CARVEDILOL PHOSPHATE CAPSULE, EXTENDED RELEASE;ORAL 10MG No No AB 2017/10/25 2017/10/25 Prescription
002 CARVEDILOL PHOSPHATE CARVEDILOL PHOSPHATE CAPSULE, EXTENDED RELEASE;ORAL 20MG No No AB 2017/10/25 Prescription
003 CARVEDILOL PHOSPHATE CARVEDILOL PHOSPHATE CAPSULE, EXTENDED RELEASE;ORAL 40MG No Yes AB 2017/10/25 Prescription
004 CARVEDILOL PHOSPHATE CARVEDILOL PHOSPHATE CAPSULE, EXTENDED RELEASE;ORAL 80MG No No AB 2017/10/25 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
审批日期提交号审批结论提交分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2017/10/25 ORIG-1(原始申请) Approval
>>>补充申请<<<
审批日期提交号审批结论补充类别或审批类型审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2024/04/16 SUPPL-5(补充) Approval Labeling-Package Insert,Labeling-Patient Package Insert STANDARD
2024/04/16 SUPPL-2(补充) Approval Labeling-Package Insert STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
001 PC 2018/05/07**本条是由Drugfuture回溯的历史信息**
002 PC 2018/05/07**本条是由Drugfuture回溯的历史信息**
003 PC 2018/05/07**本条是由Drugfuture回溯的历史信息**
004 PC 2018/05/07**本条是由Drugfuture回溯的历史信息**
与本品治疗等效的药品
>>>活性成分:CARVEDILOL PHOSPHATE; 剂型/给药途径:CAPSULE, EXTENDED RELEASE;ORAL; 规格:10MG; 治疗等效代码:AB<<<
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
022012 001 NDA COREG CR CARVEDILOL PHOSPHATE CAPSULE, EXTENDED RELEASE;ORAL 10MG Prescription Yes No AB 2006/10/20 WAYLIS THERAP
090132 001 ANDA CARVEDILOL PHOSPHATE CARVEDILOL PHOSPHATE CAPSULE, EXTENDED RELEASE;ORAL 10MG Prescription No No AB 2017/10/25 SUN PHARM INDUSTRIES
204717 001 ANDA CARVEDILOL PHOSPHATE CARVEDILOL PHOSPHATE CAPSULE, EXTENDED RELEASE;ORAL 10MG Prescription No No AB 2018/05/07 IMPAX LABS INC
>>>活性成分:CARVEDILOL PHOSPHATE; 剂型/给药途径:CAPSULE, EXTENDED RELEASE;ORAL; 规格:20MG; 治疗等效代码:AB<<<
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
022012 002 NDA COREG CR CARVEDILOL PHOSPHATE CAPSULE, EXTENDED RELEASE;ORAL 20MG Prescription Yes No AB 2006/10/20 WAYLIS THERAP
090132 002 ANDA CARVEDILOL PHOSPHATE CARVEDILOL PHOSPHATE CAPSULE, EXTENDED RELEASE;ORAL 20MG Prescription No No AB 2017/10/25 SUN PHARM INDUSTRIES
204717 002 ANDA CARVEDILOL PHOSPHATE CARVEDILOL PHOSPHATE CAPSULE, EXTENDED RELEASE;ORAL 20MG Prescription No No AB 2018/05/07 IMPAX LABS INC
>>>活性成分:CARVEDILOL PHOSPHATE; 剂型/给药途径:CAPSULE, EXTENDED RELEASE;ORAL; 规格:40MG; 治疗等效代码:AB<<<
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
022012 003 NDA COREG CR CARVEDILOL PHOSPHATE CAPSULE, EXTENDED RELEASE;ORAL 40MG Prescription Yes No AB 2006/10/20 WAYLIS THERAP
090132 003 ANDA CARVEDILOL PHOSPHATE CARVEDILOL PHOSPHATE CAPSULE, EXTENDED RELEASE;ORAL 40MG Prescription No Yes AB 2017/10/25 SUN PHARM INDUSTRIES
204717 003 ANDA CARVEDILOL PHOSPHATE CARVEDILOL PHOSPHATE CAPSULE, EXTENDED RELEASE;ORAL 40MG Prescription No No AB 2018/05/07 IMPAX LABS INC
>>>活性成分:CARVEDILOL PHOSPHATE; 剂型/给药途径:CAPSULE, EXTENDED RELEASE;ORAL; 规格:80MG; 治疗等效代码:AB<<<
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
022012 004 NDA COREG CR CARVEDILOL PHOSPHATE CAPSULE, EXTENDED RELEASE;ORAL 80MG Prescription Yes No AB 2006/10/20 WAYLIS THERAP
090132 004 ANDA CARVEDILOL PHOSPHATE CARVEDILOL PHOSPHATE CAPSULE, EXTENDED RELEASE;ORAL 80MG Prescription No No AB 2017/10/25 SUN PHARM INDUSTRIES
204717 004 ANDA CARVEDILOL PHOSPHATE CARVEDILOL PHOSPHATE CAPSULE, EXTENDED RELEASE;ORAL 80MG Prescription No No AB 2018/05/07 IMPAX LABS INC
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2025 DrugFuture->U.S. FDA Drugs Database